By Erin Marie Daly ( April 19, 2007, 12:00 AM EDT) -- A protracted legal battle between Teva Pharmaceuticals USA and Abbott Laboratories took a new turn on Tuesday, with Teva filing a lawsuit seeking a declaratory judgment that its marketing of a generic version of Abbott's extended-release antibiotic Biaxin is in line with a settlement the companies reached last August....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.